Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Mar 7, 2005; 11(9): 1373-1377
Published online Mar 7, 2005. doi: 10.3748/wjg.v11.i9.1373
Table 1 Open-field activities and sucrose intake test of rats (mean±SD).
GroupCases nRearing/5 minCrossing/5 minSucrose intake mL/24 h
Normal1032.20±11.1482.50±29.6242.70±10.24
Model5013.96±5.57b37.80±12.32b28.02±8.91b
Table 2 Effects of RAS capsule on SOD activity, MDA content and COX-2 expression in the colon tissue of depression model rats (n =10, mean±SD).
GroupDose (mg/kg)SOD (U/mg prot)MDA (nmoL/mg prot)COX-2 (A/%)
Normal-84.45±22.312.55±0.704.87±1.65
Model-53.39±11.15d10.34±2.77d53.2±68.16a
5-ASA10072.73±12.60bc3.19±1.15b24.59±9.14bd
RAS30070.81±12.36bc2.92±0.75b50.40±10.66d
RAS60073.30±15.30bc3.19±1.08b28.83±9.48bd
RAS90069.09±11.03bc3.26±1.24b27.04±9.56bd
Table 3 Effects of RAS capsule on the content of iNOS and NO in colon tissue of depression model rats (n =10, mean±SD).
GroupDose (mg/kg)iNOS (U/mg prot)NO (mmoL/g prot)
Normal-0.25±0.164.761.55
Model-1.11±0.44d11.28±5.66d
5-ASA1000.63±0.42bc5.89±2.10d
RAS3000.65±0.31ac5.99±2.73b
RAS6000.58±0.22bc6.87±1.96a
RAS9000.64±0.33bc6.5±01.58a